Menu
 

Search abstracts


An survey of therapeutic drug monitor of prophylactic voriconazole for children with cancer

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: TSAI, Ching-Yi (MacKay Memorial Hospital, Pharmacy)
  • Co-author(s): Ching-Yi Tsai: Division of Clinical Pharmacy, Department of Pharmacy, MacKay Memorial Hospital, Taipei, Taiwan, Province of China
    Chien-Hung Lu
    Wei-Ying Lee
    Ting-Chi Yeh: Division Hematology/Oncology, Department of Pediatrics, MacKay Memorial Hospital, Taipei, Taiwan, Province of China
  • Abstract:

    Background

    Children with cancer receiving intensive chemotherapy are at high risk for invasive fungal infection. The benefit of preventing life-threatening fungal infection by prophylactic voriconazole (VCZ) in children with cancer was proven. The relationship between therapeutic drug monitor (TDM) of prophylactic VCZ and breakthrough fungal..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses